90 Matching Annotations
  1. Apr 2022
  2. Mar 2022
  3. Feb 2022
  4. Jan 2022
  5. Dec 2021
  6. Nov 2021
  7. Oct 2021
  8. Sep 2021
    1. Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., Gallagher, E., Charlett, A., Angelis, D. D., Presanis, A. M., Dabrera, G., Koshy, C., Ash, A., Wise, E., Moore, N., … Gunson, R. (2021). Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00475-8

  9. Jul 2021
  10. Jun 2021
  11. May 2021
    1. Jarrad Hall. (2021, May 9). There’s a lot of speculation that COVID may become less virulent. This is still an old concept in the field, akin to aerosol vs droplet. In my own field it was assumed that resistance came at the expense of virulence. [Tweet]. @CdrHBiscuitIII. https://twitter.com/CdrHBiscuitIII/status/1391265635749957632

  12. Mar 2021
  13. Feb 2021
  14. Jan 2021
  15. Dec 2020
    1. Emily. J. Miller. - FDA {@FDASpox} (2020) Convalescent plasma has shown to be beneficial for 35% of patients. This risk reduction figure - shown in chart below - is from @MayoClinic data from expanded access program that was analyzed by FDAA for the emergency use authorization announced today. Twitter. Retrieved from: https://twitter.com/FDASpox/status/1297706985039835136

  16. Oct 2020
  17. Sep 2020
  18. Aug 2020
    1. Malani, A., Soman, S., Asher, S., Novosad, P., Imbert, C., Tandel, V., Agarwal, A., Alomar, A., Sarker, A., Shah, D., Shen, D., Gruber, J., Sachdeva, S., Kaiser, D., & Bettencourt, L. M. A. (2020). Adaptive Control of COVID-19 Outbreaks in India: Local, Gradual, and Trigger-based Exit Paths from Lockdown (Working Paper No. 27532; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27532

  19. Jul 2020
  20. Jun 2020
  21. May 2020
  22. Apr 2020